Thomas White International’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-55
Closed -$5K – 352
2016
Q4
$5K Hold
55
– – ﹤0.01% 284
2016
Q3
$4K Sell
55
-55
-50% -$4.37K ﹤0.01% 276
2016
Q2
$8K Sell
110
-250
-69% -$18.2K ﹤0.01% 212
2016
Q1
$25K Hold
360
– – ﹤0.01% 207
2015
Q4
$22K Hold
360
– – ﹤0.01% 230
2015
Q3
$19K Hold
360
– – ﹤0.01% 272
2015
Q2
$21K Buy
360
+120
+50% +$6.7K ﹤0.01% 269
2015
Q1
$14K Hold
240
– – ﹤0.01% 282
2014
Q4
$13K Hold
240
– – ﹤0.01% 287
2014
Q3
$11K Hold
240
– – ﹤0.01% 291
2014
Q2
$10K Hold
240
– – ﹤0.01% 316
2014
Q1
$11K Hold
240
– – ﹤0.01% 293
2013
Q4
$12K Hold
240
– – ﹤0.01% 301
2013
Q3
$10K Hold
240
– – ﹤0.01% 316
2013
Q2
$8K Buy
+240
New +$7.9K ﹤0.01% 294

Other funds holding WST

Thomas White International's WST Position: Q1 2017 in Review

Thomas White International sold out of West Pharmaceutical (WST) in Q1 2017, closing a stake of 55 shares — an estimated $5K sold.

Thomas White International first reported a position in WST in Q2 2013 and held it in 15 quarters. The position peaked at $25K in Q1 2016. 295 funds tracked by Wall St. Rank hold WST as of Q1 2017.

  • Thomas White International reported no remaining West Pharmaceutical position as of Q1 2017 after selling out during the quarter.
  • Thomas White International sold 55 West Pharmaceutical shares in Q1 2017, an estimated $5K.
  • Thomas White International first reported a position in West Pharmaceutical in Q2 2013 and held it in 15 quarters.
  • Thomas White International's West Pharmaceutical position peaked at $25K in Q1 2016.
  • 295 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on Thomas White International's 13F filing for Q1 2017, filed 10 May 2017.